Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 1.2B | 1.4B | 1.1B | 1.2B |
Cost of revenue | 640M | 683M | 583M | 607M |
Gross profit | 609M | 702M | 506M | 579M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 211M | 186M | 211M | 165M |
Operating income | 337M | 452M | 237M | 358M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 53M | 48M | 54M | 50M |
Other income expense | 27M | 23M | 92M | 9M |
Pretax income | 311M | 427M | 275M | 317M |
Tax provision | 77M | 93M | 64M | 78M |
Net income | 234M | 334M | 211M | 239M |
Basic EPS | 0.8 | 1.2 | 0.7 | 0.8 |
Diluted EPS | 0.8 | 1.2 | 0.7 | 0.8 |
Basic average shares | 292M | 283M | 283M | 282M |
Diluted average shares | 293M | 285M | 284M | 284M |
EBITDA | 399M | 516M | 296M | 415M |
Net income from continuing op. | 235M | 334M | 211M | 238M |
Minority interests | -3M | -3M | -1M | -5M |
Preferred stock dividends | 3M | 4M | 3M | 3M |